What real-world data will regulators consider in Europe?

A 2024 Data Quality Framework (DQF) from the European Medicines Agency (EMA) aims to provide some guidance for drug manufacturers. Here is a summary of that document. Factors to be considered when evaluating RWD Key factors to be considered in the EMA’s DQF include: Reliability: Are the data correct?Extensiveness: Are the data enoughCoherence: Are the…

Read More

When Drug Price Transparency Isn’t Enough

By KRISTINA SMITH & PHIYEN NGUYEN Policymakers and advocates often promote drug price transparency to lower costs and improve equity. While transparency is an important first step toward accountability and informed public budgeting, it does not guarantee affordable prices or fair access to medicines. Transparency Has Some Benefits Drug price transparency helps show how and…

Read More

Complaints About Gaps in Medicare Advantage Networks Are Common. Federal Enforcement Is Rare.

Along with the occasional aches and pains, growing older can bring surprise setbacks and serious diseases. Longtime relationships with doctors people trust often make even bad news more tolerable. Losing that support — especially during a health crisis — can be terrifying. That’s why little-known federal requirements are supposed to protect people with privately run…

Read More

How will new H-1B fees impact rural hospitals?

On September 19, 2025, an executive order increased the fee for new H-1B petitions from approximately $3500 to $100 000 per applicant. How is this policy likely to impact the healthcare workforce in the U.S.? A paper by Liu et al. (2025) uses Department of Labor data on certified Labor Condition Applications (LCAs) supporting H-1B visas…

Read More

Nabla — It’s been a rocketship

I met the Nabla management team two years ago. Two years later they have ridden the wave of AI scribing to be one of the leaders in the field. At HLTH this year, I caught up with CEO Alex Lebrun and COO Delphine Groll to check in on their growth (150 customers and 100K users)…

Read More